Meridia Warning.com  
Meridia Warning.com
Home
About Us
Resources
FAQs
Community
Testimonials
Contact Us
 

Pennsylvania Prescription Lawyers
Finding the right personal injury or product liability lawyer can be difficult. Munley, Munley & Cartwright is sensitive to the emotions and pain that you and your family are experiencing and we strive to provide accurate information to help you decide if you have legal recourse and should contact a lawyer.

PENNSYLVANIA MEDICAL MALPRACTICE LAWYERS
PENNSYLVANIA PERSONAL INJURY  LAWYERS
www.munley.com

In 1997 the FDA approved Meridia (sibutramine) a popular prescription medication marketed by Abbott Laboratories. Meridia is an appetite suppressant to be used along with a reduced-calorie diet to help manage obesity. The drug works on two brain chemicals that control appetite and make patients feel full. It is recommended for people who are obese (about 30 pounds or more over a healthy weight).

The FDA approved it for prescription use after much debate about its side effects and potential risks. One of the agency's medical officers, Dr. Eric Colman, expressed great concern about sibutramine's effects on blood pressure.

It is estimated that over 8.6 million people in 70 countries have used Meridia. It is an orally administered controlled substance, meaning some patients could become addicted.

In March 2002, Public Citizen, a US consumer watchdog group, asked the FDA to recall Meridia based on reports of death and adverse reactions noted from voluntary submissions by US physicians and hospitals.

According to the petition submitted by Public Citizen, as of September 2001 there have been almost 400 serious adverse reactions reported to the FDA since Meridia was first marketed in February 1998. These serious reactions have included 29 deaths, over 150 patients hospitalized and approximately 150 patients diagnosed with a serious heart condition know as arrhythmia.

The Italian Health Ministry has suspended sales of the drug after reports of two related deaths, two women ages 28 and 45. Italian officials said they received 50 complaints about side-effects from sibutramine (Reductil in Italy) (Chicago Tribune, March 9, 2002).

In France, officials reported 99 cases of side effects from sibutramine, 10 of them serious (Chicago Tribune, March 16, 2002). Last year in Great Britain, the Drug and Therapeutics Bulletin, published by the Consumers' Association, warned the drug has limited benefits and unwanted side effects. There have been reports of as many as 103 serious adverse reactions in people using the drug in France and the UK, including two deaths.

Side Effects of Meridia

To see if you have Meridia related case, click here
 

 
Disclaimer
 
 
Copyright © 2003 -   Meridia Warning . com - Munley, Munley & Cartwright, P.C., Attorneys at Law - Scranton, PA
Pennsylvania Law Firm handling Dangerous Products, Meridia - Sibutramine Arrhythmia Claims,
Including Representation in Product Liability Law, Personal Injury, and Wrongful Death.
 
Site by
Consultwebs.com, Inc. | Lawyers Marketing - Webs for Lawyers | Law Firms

DISCLAIMER: Attorney Advertising. Prior Results Do Not Guarantee a Similar Outcome.
Representation in jurisdictions where our attorneys are not already licensed is performed in conjunction with local
counsel / lawyers - at no additional legal fees to our clients - and with permission of the court.